Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppina Guarino

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Expert Opinion on Drug Safety|March 23, 2018
A randomized, open-label, comparative, crossover trial on preference, efficacy, and safety profiles of lispro insulin u-100 versus concentrated lispro insulin u-200 in patients with type 2 diabetes mellitus: a possible contribution to greater treatment adherenceSandro Gentile, Alessandra Fusco, Sara Colarusso, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 20, 2020
Insulin-Induced Skin Lipohypertrophy in Type 2 Diabetes: a Multicenter Regional Survey in Southern ItalySandro Gentile, Giuseppina Guarino, Teresa Della Corte, et al.
European Heart Journal. Imaging Methods and Practice|November 21, 2025
Intra-plaque vascularization assessed in contrast-enhanced ultrasound predicts cardiovascular events in type 2 diabetes with no significant carotid atherosclerotic stenosis: a prospective study with therapeutic implications for SGLT2 inhibitor useRaffaele Marfella, Ludovica Vittoria Marfella, Carlo Fumagalli, et al.
International Journal of Molecular Sciences|October 29, 2025
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective StudyCelestino Sardu, Ludovica Vittoria Marfella, Carlo Fumagalli, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Expert Opinion on Drug Safety|March 23, 2018
A randomized, open-label, comparative, crossover trial on preference, efficacy, and safety profiles of lispro insulin u-100 versus concentrated lispro insulin u-200 in patients with type 2 diabetes mellitus: a possible contribution to greater treatment adherenceSandro Gentile, Alessandra Fusco, Sara Colarusso, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 20, 2020
Insulin-Induced Skin Lipohypertrophy in Type 2 Diabetes: a Multicenter Regional Survey in Southern ItalySandro Gentile, Giuseppina Guarino, Teresa Della Corte, et al.
European Heart Journal. Imaging Methods and Practice|November 21, 2025
Intra-plaque vascularization assessed in contrast-enhanced ultrasound predicts cardiovascular events in type 2 diabetes with no significant carotid atherosclerotic stenosis: a prospective study with therapeutic implications for SGLT2 inhibitor useRaffaele Marfella, Ludovica Vittoria Marfella, Carlo Fumagalli, et al.
International Journal of Molecular Sciences|October 29, 2025
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective StudyCelestino Sardu, Ludovica Vittoria Marfella, Carlo Fumagalli, et al.
Pageof 3